Congrats to Romesh and team!
Marrow Therapeutics Launches with $173 Million to Develop Genetic Medicines for Bone Marrow Disorders marrowtx.com/news/marrow-the…
149
BIO CEO: American biotech needs a coordinated plan to beat China — now statnews.com/2026/11/10/chin… via @statnews
1
256
Exciting Ph 2 data from $PEPG today. Just be cautious comparing splicing correction across studies (is their 22-gene panel the same as Dyne CASI?), and note PEPG and DYN have the same vHOT results (3.9 and 3.8 s vs. placebo), though only n=6 for PEPG
[no position in either]
This is incredible. Datasets appear to be highly relevant and accurate based on a couple quick tests. Wow!
Very excited to introduce Paperclip Datasets!
Curate your own datasets from millions of papers in minutes. Just describe the dataset you want to build!
As example, we release the largest dataset of 20k half-life human measurements curated from 2400+ drugs💊
🖇️ Try it: paperclip.gxl.ai/datasets
📝 Blog: gxl.ai/blog/introducing-pape…
📊 Half-life dataset: huggingface.co/datasets/gxl-…
Wow big acquisition in the CDMO space. 5 sites, 1100 employees, "low-to-mid triple-digit M CHF" price.
Lonza Signs Agreement to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US Presence
lonza.com/news/2026-11-03-07…
10
961
New post from Anthropic on what they've been up to in biopharma. Some interesting projects
Early progress on accelerating drug development with Claude anthropic.com/research/early…
1
6
597
Rob Shaffer retweeted
Poll for biotech entrepreneurs and biotech/pharma BD folks:
What do you use for your fundraising or BD tracker?
I personally use excel, which I kind of hate.
If you use software or SaaS, please reply with the name. Thanks!
45%Excel or Google Sheets
12%Software or SaaS app
43%Show me the answers
126 votes • Final results Rob Shaffer retweeted
IMO… it is a mistake to “try to increase U.S. competitiveness through protectionism.” The new rule “may make it easier for non-U.S. companies to succeed through manufacturing in China. This wouldn’t help our global competitiveness.”
IMO… let’s instead kick ass with American ingenuity!
biocentury.com/article/66129…
Buyout firm EQT to acquire Qiagen for $10.8 billion reuters.com/legal/transactio…
Love the idea of modular fill/finish facilities/pods -
Mark Cuban wants to crack open the market for rare disease treatments
statnews.com/2026/10/21/mark…
1
3
438
Go Wayne!
Estuary Biotherapeutics is on a mission to make #ADPKD history through targeted gene therapies designed to address the disease’s underlying genetic cause.
Led by CEO Wayne Sackett and built on landmark discoveries from scientific co-founders Stefan Somlo, MD, and Michael Caplan, MD, PhD, at @YaleMed, we're launching with $103 million to advance our lead programs, EST-201 and EST-101, toward clinical proof of concept.
Watch our story and learn more at estuarybio.com.
estuarybio.com/news/estuary-…
138
Very much yes @JakeAuch
Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China statnews.com/2026/10/15/auch…
144
Cardiomyopathy space continues to pick up steam. Souffle yesterday, AZ today, more to come!
$AZ. Insitro. $1.46 billion in biobucks.
MASH and cardiommyopathy.
astrazeneca.com/media-centre…
1
238
Another big raise for a pair of VC funds. Congrats to Orbimed
OrbiMed Raises $3 Billion Across Global and Asia Private Equity Funds orbimed.com/orbimed-raises-3…
199
Rob Shaffer retweeted
This is a meaningful step to bring better coordination around FDA initiatives to make the process for developing treatments for rare diseases more efficient. Will help accelerate new policy development.
bloomberg.com/news/articles/…
Impressive round and syndicate for a preclinical company. Interesting - 2nd program still targeting PLN but going after HFrEF now (vs R14del DCM)
Souffle Therapeutics Announces Oversubscribed $135 Million Series B Financing to Advance Lead Clinical Programs and Continued Pipeline Progress souffletx.com/news/press-rel…
This is good -
50 years ago, my colleagues and I pursued basic research science that became revolutionary statnews.com/2026/10/09/robe…










